Suppr超能文献

埃博拉病毒糖蛋白被组织蛋白酶 L 加工的生化和结构特征:对病毒进入和免疫原性的影响。

Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.

机构信息

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health,Room 4502, Building 40, MSC-3005, 40 Convent Drive, Bethesda, Maryland 20892-3005, USA.

出版信息

J Virol. 2010 Mar;84(6):2972-82. doi: 10.1128/JVI.02151-09. Epub 2010 Jan 6.

Abstract

Ebola virus (EBOV) cellular attachment and entry is initiated by the envelope glycoprotein (GP) on the virion surface. Entry of this virus is pH dependent and associated with the cleavage of GP by proteases, including cathepsin L (CatL) and/or CatB, in the endosome or cell membrane. Here, we characterize the product of CatL cleavage of Zaire EBOV GP (ZEBOV-GP) and evaluate its relevance to entry. A stabilized recombinant form of the EBOV GP trimer was generated using a trimerization domain linked to a cleavable histidine tag. This trimer was purified to homogeneity and cleaved with CatL. Characterization of the trimeric product by N-terminal sequencing and mass spectrometry revealed three cleavage fragments, with masses of 23, 19, and 4 kDa. Structure-assisted modeling of the cathepsin L-cleaved ZEBOV-GP revealed that cleavage removes a glycosylated glycan cap and mucin-like domain (MUC domain) and exposes the conserved core residues implicated in receptor binding. The CatL-cleaved ZEBOV-GP intermediate bound with high affinity to a neutralizing antibody, KZ52, and also elicited neutralizing antibodies, supporting the notion that the processed intermediate is required for viral entry. Together, these data suggest that CatL cleavage of EBOV GP exposes its receptor-binding domain, thereby facilitating access to a putative cellular receptor in steps that lead to membrane fusion.

摘要

埃博拉病毒(EBOV)的细胞附着和进入是由病毒表面包膜糖蛋白(GP)启动的。该病毒的进入依赖于 pH 值,并与蛋白酶(包括组织蛋白酶 L(CatL)和/或 CatB)在内体或细胞膜中对 GP 的裂解有关。在这里,我们描述了 CatL 对扎伊尔 EBOV GP(ZEBOV-GP)的裂解产物的特征,并评估了其与进入的相关性。使用与可切割组氨酸标签连接的三聚体化结构域生成了 EBOV GP 三聚体的稳定重组形式。该三聚体被纯化至均一性并与 CatL 切割。通过 N 端测序和质谱对三聚体产物的特征进行分析,揭示了三个裂解片段,分子量分别为 23、19 和 4 kDa。基于结构的 CatL 切割的 ZEBOV-GP 模型表明,切割去除了一个糖基化聚糖帽和粘蛋白样结构域(MUC 结构域),并暴露了涉及受体结合的保守核心残基。CatL 切割的 ZEBOV-GP 中间体能与中和抗体 KZ52 高亲和力结合,并且还能诱导中和抗体,支持处理后的中间体能被用于病毒进入的观点。这些数据表明,CatL 对 EBOV GP 的切割暴露了其受体结合域,从而促进了在导致膜融合的步骤中进入潜在的细胞受体。

相似文献

2
Cathepsin B & L are not required for ebola virus replication.
PLoS Negl Trop Dis. 2012;6(12):e1923. doi: 10.1371/journal.pntd.0001923. Epub 2012 Dec 6.
4
Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.
mBio. 2014 Jan 28;5(1):e00862-13. doi: 10.1128/mBio.00862-13.
6
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.
J Virol. 2007 Dec;81(24):13378-84. doi: 10.1128/JVI.01170-07. Epub 2007 Oct 10.

引用本文的文献

1
Mapping Immunological, Host Receptor Binding Determinants, and Cathepsin Cleavage Site of EBOV Glycoprotein Utilizing the Qubevirus Platform.
ACS Omega. 2025 Mar 31;10(14):14283-14295. doi: 10.1021/acsomega.5c00408. eCollection 2025 Apr 15.
2
Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies.
Antibodies (Basel). 2025 Mar 5;14(1):22. doi: 10.3390/antib14010022.
3
A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus.
Front Immunol. 2024 Jul 16;15:1429909. doi: 10.3389/fimmu.2024.1429909. eCollection 2024.
5
7
Virus-Mediated Cell-Cell Fusion.
Int J Mol Sci. 2020 Dec 17;21(24):9644. doi: 10.3390/ijms21249644.
8
Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity.
Front Immunol. 2020 Nov 4;11:586595. doi: 10.3389/fimmu.2020.586595. eCollection 2020.

本文引用的文献

1
Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins.
Proc Natl Acad Sci U S A. 2009 May 12;106(19):8003-8. doi: 10.1073/pnas.0807578106. Epub 2009 Apr 28.
2
The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding.
J Virol. 2009 Apr;83(7):2883-91. doi: 10.1128/JVI.01956-08. Epub 2009 Jan 14.
3
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.
Nature. 2008 Jul 10;454(7201):177-82. doi: 10.1038/nature07082.
5
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.
J Virol. 2007 Dec;81(24):13378-84. doi: 10.1128/JVI.01170-07. Epub 2007 Oct 10.
6
Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events.
J Virol. 2007 Jul;81(14):7702-9. doi: 10.1128/JVI.02433-06. Epub 2007 May 2.
7
Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination.
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15987-91. doi: 10.1073/pnas.0607564103. Epub 2006 Oct 16.
8
Tyro3 family-mediated cell entry of Ebola and Marburg viruses.
J Virol. 2006 Oct;80(20):10109-16. doi: 10.1128/JVI.01157-06.
9
Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry.
Virus Res. 2006 Nov;121(2):205-14. doi: 10.1016/j.virusres.2006.06.002. Epub 2006 Jul 12.
10
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor.
J Biol Chem. 2006 Jun 9;281(23):15951-8. doi: 10.1074/jbc.M601796200. Epub 2006 Apr 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验